Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US.
Di Fusco M, Cappelleri JC, Anatale-Tardiff L, Coetzer H, Yehoshua A, Alvarez MB, Allen KE, Porter TM, Puzniak L, Cha-Silva AS, Lopez SMC, Sun X. Di Fusco M, et al. Among authors: allen ke. Healthcare (Basel). 2023 Oct 21;11(20):2790. doi: 10.3390/healthcare11202790. Healthcare (Basel). 2023. PMID: 37893865 Free PMC article.
Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy.
Di Fusco M, Sun X, Anatale-Tardiff L, Yehoshua A, Coetzer H, Alvarez MB, Allen KE, Porter TM, Puzniak L, Lopez SMC, Cappelleri JC. Di Fusco M, et al. Among authors: allen ke. Vaccines (Basel). 2023 Oct 31;11(11):1669. doi: 10.3390/vaccines11111669. Vaccines (Basel). 2023. PMID: 38006001 Free PMC article.
Associations between symptom-based long COVID clusters and long-term quality of life, work and daily activities among individuals testing positive for SARS-CoV-2 at a national retail pharmacy.
Di Fusco M, Cappelleri JC, Yehoshua A, Craig KJT, Alvarez MB, Allen KE, Porter TM, Lopez SMC, Puzniak L, Sun X. Di Fusco M, et al. Among authors: allen ke. J Patient Rep Outcomes. 2024 Oct 22;8(1):122. doi: 10.1186/s41687-024-00797-7. J Patient Rep Outcomes. 2024. PMID: 39436613 Free PMC article.
Latent class analysis of post-acute sequelae of SARS-CoV-2 infection.
Sun X, DeShazo JP, Anatale-Tardiff L, Di Fusco M, Allen KE, Porter TM, Coetzer H, Lopez SMC, Puzniak L, Cappelleri JC. Sun X, et al. Among authors: allen ke. J Biopharm Stat. 2024 Nov 16:1-16. doi: 10.1080/10543406.2024.2424844. Online ahead of print. J Biopharm Stat. 2024. PMID: 39550613
Oral COVID-19 Antiviral Uptake Among a Highly Vaccinated US Cohort of Adults With SARS-CoV-2 Infection Between December 2021 and October 2022.
Shen Y, Robertson MM, Kulkarni SG, Puzniak L, Zamparo JM, Allen KE, Porter TM, Qasmieh SA, Grov C, Srivastava A, Zimba R, McLaughlin JM, Nash D. Shen Y, et al. Among authors: allen ke. Open Forum Infect Dis. 2023 Dec 21;11(2):ofad674. doi: 10.1093/ofid/ofad674. eCollection 2024 Feb. Open Forum Infect Dis. 2023. PMID: 38344131 Free PMC article.
Barriers to initial COVID-19 booster among U.S. adults who completed a primary vaccine series in the CHASING COVID cohort, September 2021 - October 2022.
Rane MS, Shen Y, Robertson MK, Penrose K, Srivastava A, Puzniak L, Allen KE, Porter TM, Kulkarni S, You W, Berry A, Parcesepe AM, Grov C, Zimba R, Nash D. Rane MS, et al. Among authors: allen ke. Am J Epidemiol. 2024 Jul 16:kwae209. doi: 10.1093/aje/kwae209. Online ahead of print. Am J Epidemiol. 2024. PMID: 39013788
Real-world effectiveness of original BNT162b2 mRNA COVID-19 against symptomatic Omicron infection among children 5-11 years of age in Brazil: A prospective test-negative design study.
Rodrigues CO, Spinardi J, Rosa RG, Falavigna M, de Souza EM, Manfio JL, de Souza AP, de Araujo CLP, Cohen M, Barbosa GRGDV, Silva FKR, Sganzerla D, da Silva MMD, Ferreira D, Kunkel NT, Camargo NI, Sarturi JC, Guilhem MC, de Oliveira JC, Lopes CC, Widmar F, Barufi LK, da Silva GN, Gradia DF, Brandalize APC, Royer CA, Luiz RM, Baura VA, Abreu H, Poitevin CG, Kucharski GA, Pedrotti F, Valluri SR, Srivastava A, Julião VW, Melone OC, Allen KE, Kyaw MH, Castillo GDCM, McLaughlin JM; Toledo BNT162b2 Study Group Investigators. Rodrigues CO, et al. Among authors: allen ke. Immunol Lett. 2024 Oct;269:106903. doi: 10.1016/j.imlet.2024.106903. Epub 2024 Jul 26. Immunol Lett. 2024. PMID: 39069096
168 results